D. Lynn Kirkpatrick
Overview
D. Lynn Kirkpatrick received $156K in total compensation at Ensysce Biosciences in 2020. D Kirkpatrick also received an average of $203K at Oncothyreon between 2006 and 2007.
Source: SEC filings on December 17, 2021 and April 29, 2008.
Related executives
We found 16 more executives who work or worked at Ensysce Biosciences and Oncothyreon.
David Humphrey
Ensysce Biosciences
Chief Financial Officer
Lynn Kirkpatrick
Ensysce Biosciences
Chief Executive Officer
Geoff Birkett
Ensysce Biosciences
Chief Commercial Officer
Richard Wright
Ensysce Biosciences
Chief Business Officer
Scott Myers
Oncothyreon
Chief Executive Officer
Robert Kirkman
Oncothyreon
Chief Executive Officer
Scott Peterson
Oncothyreon
Chief Scientific Officer
Julia Eastland
Oncothyreon